Considerations and Changes in the Evaluation, Management, and Outcomes in the Management of Diverticular Disease: The Diagnosis, Pathology, and Treatment of Diverticular Colitis

Robert J. Kucejko; Juan L. Poggio

doi:10.1055/s-0037-1607467

Clinics in Colon and Rectal Surgery, Inhaltsverzeichnis

Clin Colon Rectal Surg 2018; 31(04): 221-225
DOI: 10.1055/s-0037-1607467

Review Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Considerations and Changes in the Evaluation, Management, and Outcomes in the Management of Diverticular Disease: The Diagnosis, Pathology, and Treatment of Diverticular Colitis

Robert J. Kucejko

¹Department of Surgery, Division of Colon and Rectal Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania

,

Juan L. Poggio

¹Department of Surgery, Division of Colon and Rectal Surgery, Drexel University College of Medicine, Philadelphia, Pennsylvania

› Institutsangaben

Abstract

Diverticular colitis, also known as segmental colitis associated with diverticulosis, is a colonic inflammatory disorder on the spectrum of inflammatory bowel disease (IBD). The disease consists of macroscopic and microscopic inflammation affecting inter-diverticular mucosa, sparing peri-diverticular mucosa, with inflammation confined to the descending and sigmoid colon. The disease likely arises from the altered immune response of an individual, genetically susceptible to the IBD spectrum of diseases. Patients with segmental colitis associated with diverticulosis (SCAD) are typically older, and likely represent a subgroup of IBD—susceptible patients who lacked an environmental trigger until that point in their life. Most patients remain in remission with initial treatments of mesalamine or topical steroids, and maintenance mesalamine afterwards. Only the most severe form of the disease necessitates immunomodulatory therapy and the consideration of surgery.

Keywords

diverticular - segmental - sigmoid - diverticulosis - colitis

Volltext

Referenzen

References
1 Matrana MR, Margolin DA. Epidemiology and pathophysiology of diverticular disease. Clin Colon Rectal Surg 2009; 22 (03) 141-146
2 Tursi A. Segmental colitis associated with diverticulosis: complication of diverticular disease or autonomous entity?. Dig Dis Sci 2011; 56 (01) 27-34
3 Schmidt GT, Lennard-Jones JE, Morson BC, Young AC. Crohn's disease of the colon and its distinction from diverticulitis. Gut 1968; 9 (01) 7-16
4 Cawthorn SJ, Gibbs NM, Marks GG. Segmental colitis: a new complication of diverticular disease. Gut 1983; 24 (05) A500
5 Sladen GE, Filipe MI. Is segmental colitis a complication of diverticular disease?. Dis Colon Rectum 1984; 27 (08) 513-514
6 Gore S, Shepherd NA, Wilkinson SP. Endoscopic crescentic fold disease of the sigmoid colon: the clinical and histopathological spectrum of a distinctive endoscopic appearance. Int J Colorectal Dis 1992; 7 (02) 76-81
7 Pereira MC. Diverticular disease-associated colitis: progression to severe chronic ulcerative colitis after sigmoid surgery. Gastrointest Endosc 1998; 48 (05) 520-523
8 Jani N, Finkelstein S, Blumberg D, Regueiro M. Segmental colitis associated with diverticulosis. Dig Dis Sci 2002; 47 (05) 1175-1181
9 Freeman HJ. Natural history and long-term clinical behavior of segmental colitis associated with diverticulosis (SCAD syndrome). Dig Dis Sci 2008; 53 (09) 2452-2457
10 Tursi A, Elisei W, Brandimarte G. , et al. Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis down-regulates after treatment. J Gastrointestin Liver Dis 2011; 20 (04) 365-370
11 Tursi A, Elisei W, Picchio M. Incidence and prevalence of inflammatory bowel diseases in gastroenterology primary care setting. Eur J Intern Med 2013; 24 (08) 852-856
12 Tursi A, Elisei W, Brandimarte G. , et al. The endoscopic spectrum of segmental colitis associated with diverticulosis. Colorectal Dis 2010; 12 (05) 464-470
13 Taleban S, Colombel JF, Mohler MJ, Fain MJ. Inflammatory bowel disease and the elderly: a review. J Crohn's Colitis 2015; 9 (06) 507-515
14 Heresbach D, Alexandre JL, Bretagne JF. , et al; ABERMAD. Crohn's disease in the over-60 age group: a population based study. Eur J Gastroenterol Hepatol 2004; 16 (07) 657-664
15 Ludeman L, Shepherd NA. What is diverticular colitis?. Pathology 2002; 34 (06) 568-572
16 Mulhall AM, Mahid SS, Petras RE, Galandiuk S. Diverticular disease associated with inflammatory bowel disease-like colitis: a systematic review. Dis Colon Rectum 2009; 52 (06) 1072-1079
17 Imperiali G, Terpin MM, Meucci G, Ferrara A, Minoli G. Segmental colitis associated with diverticula: a 7-year follow-up study. Endoscopy 2006; 38 (06) 610-612
18 Tursi A, Elisei W, Giorgetti GM. , et al. Segmental colitis associated with diverticulosis: a 5-year follow-up. Int J Colorectal Dis 2012; 27 (02) 179-185
19 Tursi A, Inchingolo CD, Picchio M, Elisei W, Mangiola F, Gasbarrini G. Histopathology of segmental colitis associated with diverticulosis resembles inflammatory bowel diseases. J Clin Gastroenterol 2015; 49 (04) 350-351
20 Lamps LW, Knapple WL. Diverticular disease-associated segmental colitis. Clin Gastroenterol Hepatol 2007; 5 (01) 27-31
21 Makapugay LM, Dean PJ. Diverticular disease-associated chronic colitis. Am J Surg Pathol 1996; 20 (01) 94-102
22 Koutroubakis IE, Antoniou P, Tzardi M, Kouroumalis EA. The spectrum of segmental colitis associated with diverticulosis. Int J Colorectal Dis 2005; 20 (01) 28-32
23 Evans JP, Cooper J, Roediger WE. Diverticular colitis - therapeutic and aetiological considerations. Colorectal Dis 2002; 4 (03) 208-212
24 Mann NS, Hoda KK. Segmental colitis associated with diverticulosis: systematic evaluation of 486 cases with meta-analysis. Hepatogastroenterology 2012; 59 (119) 2119-2121
25 Rizzello F, Gionchetti P, D'Arienzo A. , et al. Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther 2002; 16 (06) 1109-1116
26 Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Beclomethasone dipropionate plus VSL#3 for the treatment of mild to moderate diverticular colitis: an open, pilot study. J Clin Gastroenterol 2005; 39 (07) 644-645
27 Hassan C, Zullo A, Ierardi E, Burattini O, De Francesco V, Morini S. Tumour necrosis factor alpha downregulation and therapeutic response to infliximab in a case of segmental colitis associated with diverticula. Gut 2006; 55 (04) 589-590
28 Ierardi E, Meucci G, Hassan C. , et al. Tumour necrosis factor alpha in segmental colitis associated with diverticula. Dig Dis Sci 2008; 53 (07) 1865-1868
29 Sultan K, Fields S, Panagopoulos G, Korelitz BI. The nature of inflammatory bowel disease in patients with coexistent colonic diverticulosis. J Clin Gastroenterol 2006; 40 (04) 317-321
30 Rampton DS. Diverticular colitis: diagnosis and management. Colorectal Dis 2001; 3 (03) 149-153
31 Hokama A, Kinjo F, Tomiyama R, Maeda K, Saito A, Matayoshi M. Progression of diverticular colitis to ulcerative colitis. Inflamm Bowel Dis 2005; 11 (06) 618